Journal of Clinical Endocrinology & Metabolism, Vol 60, 960-966, Copyright © 1985 by Endocrine Society

ARTICLES

Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis

JS Adams, FR Singer, MA Gacad, OP Sharma, MJ Hayes, P Vouros and MF Holick

Hypercalcemia and hypercalciuria in sarcoidosis are thought to result from the endogenous overproduction of an active vitamin D metabolite. We employed primary cultures of pulmonary alveolar macrophages from two patients with biopsy-proven pulmonary sarcoidosis and a recent or current clinical abnormality in calcium metabolism to synthesize in vitro a 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3]-like metabolite from 25- hydroxyvitamin D3 (25OHD3). The macrophage metabolite cochromatographed with [3H]1,25-(OH)2D3 on normal phase and reverse phase high performance liquid chromatography and was bound with high affinity by the chick intestinal receptor for 1,25-(OH)2D3. On UV spectroscopy, the metabolite possessed the carbon-5,7,10 (19) cis-triene chromophore characteristic of a vitamin D sterol. Electron impact mass spectrometry of trimethylsilyl ether derivatives of the metabolite revealed a mass fragmentation pattern similar to that of the trimethylsilyl ether derivative of authentic 1,25-(OH)2D3. The incubation of cultured macrophages from two patients with idiopathic pulmonary fibrosis and two with scleroderma with [3H]25OHD3 did not result in production of a metabolite with the chromatographic identity of 1,25-(OH)2D3. These data indicate that the metabolite of 25OHD3 synthesized by sarcoid macrophages in vitro is 1,25-(OH)2D3 and that the macrophage is a synthetic source of the sterol metabolite in sarcoidosis.

This article has been cited by other articles:

				G. Jones Pharmacokinetics of vitamin D toxicity Am. J. Clinical Nutrition, August 1, 2008; 88(2): 582S - 586S. [Abstract] [Full Text] [PDF]

				M. C. Iannuzzi and B. A. Rybicki Genetics of Sarcoidosis: Candidate Genes and Genome Scans Proceedings of the ATS, January 1, 2007; 4(1): 108 - 116. [Abstract] [Full Text] [PDF]

				D. D. Bikle For Whom the Bugs Toll; They Toll for D IBMS BoneKEy, April 1, 2006; 3(4): 12 - 15. [Abstract] [Full Text] [PDF]

				J. L. Vanhooke, J. M. Prahl, C. Kimmel-Jehan, M. Mendelsohn, E. W. Danielson, K. D. Healy, and H. F. DeLuca CYP27B1 null mice with LacZreporter gene display no 25-hydroxyvitamin D3-1{alpha}-hydroxylase promoter activity in the skin PNAS, January 3, 2006; 103(1): 75 - 80. [Abstract] [Full Text] [PDF]

				Y. Kinoshita, M. Taguchi, A. Takeshita, D. Miura, S. Tomikawa, and Y. Takeuchi 1,25-Dihydroxyvitamin D Suppresses Circulating Levels of Parathyroid Hormone in a Patient with Primary Hyperparathyroidism and Coexistent Sarcoidosis J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6727 - 6731. [Abstract] [Full Text] [PDF]

				M T Abreu, V Kantorovich, E A Vasiliauskas, U Gruntmanis, R Matuk, K Daigle, S Chen, D Zehnder, Y-C Lin, H Yang, et al. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density Gut, August 1, 2004; 53(8): 1129 - 1136. [Abstract] [Full Text] [PDF]

				M. Vidal, C. V. Ramana, and A. S. Dusso Stat1-Vitamin D Receptor Interactions Antagonize 1,25-Dihydroxyvitamin D Transcriptional Activity and Enhance Stat1-Mediated Transcription Mol. Cell. Biol., April 15, 2002; 22(8): 2777 - 2787. [Abstract] [Full Text] [PDF]

				P. R. Holt, N. Arber, B. Halmos, K. Forde, H. Kissileff, K. A. McGlynn, S. F. Moss, K. Fan, K. Yang, and M. Lipkin Colonic Epithelial Cell Proliferation Decreases with Increasing Levels of Serum 25-Hydroxy Vitamin D Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 113 - 119. [Abstract] [Full Text]

				U. GÖBEL, R. KETTRITZ, W. SCHNEIDER, and F. C. LUFT The Protean Face of Renal Sarcoidosis J. Am. Soc. Nephrol., March 1, 2001; 12(3): 616 - 623. [Full Text]

				D. Zehnder, R. Bland, M. C. Williams, R. W. McNinch, A. J. Howie, P. M. Stewart, and M. Hewison Extrarenal Expression of 25-Hydroxyvitamin D3-1{{alpha}}-Hydroxylase J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 888 - 894. [Abstract] [Full Text]

				S. Wu, S. Ren, H. Chen, R. F. Chun, M. A. Gacad, and J. S. Adams Intracellular Vitamin D Binding Proteins: Novel Facilitators of Vitamin D-Directed Transactivation Mol. Endocrinol., September 1, 2000; 14(9): 1387 - 1397. [Abstract] [Full Text]

				M. Conron, C. Young, and H. L. C. Beynon Calcium metabolism in sarcoidosis and its clinical implications Rheumatology, July 1, 2000; 39(7): 707 - 713. [Abstract] [Full Text] [PDF]

				G. Jones, H. Ramshaw, A. Zhang, R. Cook, V. Byford, J. White, and M. Petkovich Expression and Activity of Vitamin D-Metabolizing Cytochrome P450s (CYP1{alpha} and CYP24) in Human Nonsmall Cell Lung Carcinomas Endocrinology, July 1, 1999; 140(7): 3303 - 3310. [Abstract] [Full Text]

				X. F. Kong, X. H. Zhu, Y. L. Pei, D. M. Jackson, and M. F. Holick Molecular cloning, characterization, and promoter analysis of the human 25-hydroxyvitamin D3-1alpha -hydroxylase gene PNAS, June 8, 1999; 96(12): 6988 - 6993. [Abstract] [Full Text] [PDF]

				G. Rizzato Clinical impact of bone and calcium metabolism changes in sarcoidosis Thorax, May 1, 1998; 53(5): 425 - 429. [Full Text]

				K. Takeyama, S. Kitanaka, T. Sato, M. Kobori, J. Yanagisawa, and S. Kato 25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis. Science, September 19, 1997; 277(5333): 1827 - 1830. [Abstract] [Full Text]

				M. Rehli, S. W. Krause, M. Kreutz, and R. Andreesen Carboxypeptidase M Is Identical to the MAX.1 Antigen and Its Expression Is Associated with Monocyte to Macrophage Differentiation J. Biol. Chem., June 30, 1995; 270(26): 15644 - 15649. [Abstract] [Full Text] [PDF]